Drug Delivery · Cambridge, MA · Founded 2022 · Privately Held (backing)
Operator of a therapeutic platform intended to offer precise medicines for immune-mediated diseases. Zag Bio is based in Cambridge, MA and was founded in 2022. Its last reported valuation was $25 million in Jul 2023. It has raised $102 million across 1 recorded round; the latest was an $80 million Series A in Oct 2025.
Last reported valuation
$25.0M
Oct 2026
Priced at
—
Total raised
$102.0M
Last round
Early Stage VC (Series A)
Oct 2025
Cap table — not yet on record
Zag Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Zag Bio with a free account
·The complete investor list: 17 names
·Watch Zag Bio: the Monday email on marks, rounds and moves